92 related articles for article (PubMed ID: 26676943)
41. Elevated circulating vaspin levels were decreased by rosiglitazone therapy in T2DM patients with poor glycemic control on metformin alone.
Zhang L; Li L; Yang M; Liu H; Yang G
Cytokine; 2011 Nov; 56(2):399-402. PubMed ID: 21802961
[TBL] [Abstract][Full Text] [Related]
42. Vaspin gene expression in human adipose tissue: association with obesity and type 2 diabetes.
Klöting N; Berndt J; Kralisch S; Kovacs P; Fasshauer M; Schön MR; Stumvoll M; Blüher M
Biochem Biophys Res Commun; 2006 Jan; 339(1):430-6. PubMed ID: 16298335
[TBL] [Abstract][Full Text] [Related]
43. [Selected new atherosclerosis risk factors and markers of fibrinolysis in children and adolescents with obesity, hypertension and diabetes].
Głowińska B; Urban M; Koput A; Galar M
Przegl Lek; 2003; 60(1):12-7. PubMed ID: 12884639
[TBL] [Abstract][Full Text] [Related]
44. Circulating levels of novel adipocytokines in patients with colorectal cancer.
Fazeli MS; Dashti H; Akbarzadeh S; Assadi M; Aminian A; Keramati MR; Nabipour I
Cytokine; 2013 Apr; 62(1):81-5. PubMed ID: 23474107
[TBL] [Abstract][Full Text] [Related]
45. Circulating leptin and insulin in obese patients with and without type 2 diabetes mellitus: relation to ghrelin and oxidative stress.
Hamed EA; Zakary MM; Ahmed NS; Gamal RM
Diabetes Res Clin Pract; 2011 Dec; 94(3):434-41. PubMed ID: 21924513
[TBL] [Abstract][Full Text] [Related]
46. Insulin administration acutely decreases vaspin serum concentrations in humans.
Kovacs P; Miehle K; Sandner B; Stumvoll M; Blüher M
Obes Facts; 2013; 6(1):86-8. PubMed ID: 23466514
[TBL] [Abstract][Full Text] [Related]
47. Serum levels of pigment epithelium-derived factor (PEDF) are positively associated with visceral adiposity in Japanese patients with type 2 diabetes.
Nakamura K; Yamagishi S; Adachi H; Kurita-Nakamura Y; Matsui T; Inoue H
Diabetes Metab Res Rev; 2009 Jan; 25(1):52-6. PubMed ID: 18677713
[TBL] [Abstract][Full Text] [Related]
48. Serum visfatin, resistin and IL-18 in A group of Egyptian obese diabetic and non diabetic individuals.
Mabrouk R; Ghareeb H; Shehab A; Omar K; El-Kabarity RH; Soliman DA; Mohamed NA
Egypt J Immunol; 2013; 20(1):1-11. PubMed ID: 23888552
[TBL] [Abstract][Full Text] [Related]
49. Investigation of vaspin level in patients with acute ischemic stroke.
Cura HS; Özdemir HH; Demir CF; Bulut S; İlhan N; Inci MF
J Stroke Cerebrovasc Dis; 2014 Mar; 23(3):453-6. PubMed ID: 23594688
[TBL] [Abstract][Full Text] [Related]
50. Serum visfatin and vaspin levels in prepubertal children: effect of obesity and weight loss after behavior modifications on their secretion and relationship with glucose metabolism.
Martos-Moreno GÁ; Kratzsch J; Körner A; Barrios V; Hawkins F; Kiess W; Argente J
Int J Obes (Lond); 2011 Oct; 35(10):1355-62. PubMed ID: 21266955
[TBL] [Abstract][Full Text] [Related]
51. Association between serum vaspin level and metabolic syndrome in healthy Korean subjects.
Kim JM; Kim TN; Won JC
Metab Syndr Relat Disord; 2013 Dec; 11(6):385-91. PubMed ID: 23992351
[TBL] [Abstract][Full Text] [Related]
52. Circulating vaspin is unrelated to insulin sensitivity in a cohort of nondiabetic humans.
von Loeffelholz C; Möhlig M; Arafat AM; Isken F; Spranger J; Mai K; Randeva HS; Pfeiffer AF; Weickert MO
Eur J Endocrinol; 2010 Mar; 162(3):507-13. PubMed ID: 19952124
[TBL] [Abstract][Full Text] [Related]
53. Metformin decreases the adipokine vaspin in overweight women with polycystic ovary syndrome concomitant with improvement in insulin sensitivity and a decrease in insulin resistance.
Tan BK; Heutling D; Chen J; Farhatullah S; Adya R; Keay SD; Kennedy CR; Lehnert H; Randeva HS
Diabetes; 2008 Jun; 57(6):1501-7. PubMed ID: 18375437
[TBL] [Abstract][Full Text] [Related]
54. Circulating secreted frizzled-related protein 5 (Sfrp5) and wingless-type MMTV integration site family member 5a (Wnt5a) levels in patients with type 2 diabetes mellitus.
Lu YC; Wang CP; Hsu CC; Chiu CA; Yu TH; Hung WC; Lu LF; Chung FM; Tsai IT; Lin HC; Lee YJ
Diabetes Metab Res Rev; 2013 Oct; 29(7):551-6. PubMed ID: 23653377
[TBL] [Abstract][Full Text] [Related]
55. The impact of obesity on secretion of adiponectin multimeric isoforms differs in visceral and subcutaneous adipose tissue.
Kovacova Z; Tencerova M; Roussel B; Wedellova Z; Rossmeislova L; Langin D; Polak J; Stich V
Int J Obes (Lond); 2012 Oct; 36(10):1360-5. PubMed ID: 22143618
[TBL] [Abstract][Full Text] [Related]
56. Objectively assessed sedentary time and type 2 diabetes mellitus: a case–control study.
Hamer M; Bostock S; Hackett R; Steptoe A
Diabetologia; 2013 Dec; 56(12):2761-2. PubMed ID: 24078056
[No Abstract] [Full Text] [Related]
57. [Obesity: Progress in diagnosis and treatment; Topics, IV. Recent topics: 3. Obesity and new secretory factors; 1) Vaspin].
Wada J; Teshigawara S; Nakatsuka A; Makino H
Nihon Naika Gakkai Zasshi; 2011 Apr; 100(4):996-1001. PubMed ID: 21626837
[No Abstract] [Full Text] [Related]
58. Comment and reply on: Serum chemerin and vaspin in non-alcoholic fatty liver disease.
Dogru T; Karadurmus N; Tapan S; Genc H
Scand J Gastroenterol; 2010 Aug; 45(7-8):1000-1; author reply 1001-2. PubMed ID: 20377484
[No Abstract] [Full Text] [Related]
59. Age, obesity and diabetes mellitus.
Rao GM; Morghom LO
Indian J Med Sci; 1988 Apr; 42(4):81-8, 91, 99. PubMed ID: 3410519
[No Abstract] [Full Text] [Related]
60. Letter to the Editor: High Serum N(1)-Methylnicotinamide in Obesity and Diabetes: A Consequence of Excess Nicotinamide?
Zhou SS; Li D; Zhou Y
J Clin Endocrinol Metab; 2015 Sep; 100(9):L78-9. PubMed ID: 26339743
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
